Role of pMAPkinase, pAKT, p27 & IGF-IR as predictive markers of response to trastuzumab in patients with HER2-positive invasive breast cancer treated with neoadjuvant chemotherapy + trastuzumab in the REMAGUS02 trial. - Mathieu, M. C.; Goubar, A.; Sigal, B.; Bertheau, P.; Guinebretière, J. M.; André, F.; Pierga, J. Y.; Delaloge, S.; Giacchetti, S.; Brain, E.; Marty, M. (Cancer Research, 2012)